SCL Science Inc. (KOSDAQ:246960)
9,050.00
+200.00 (2.26%)
Last updated: Jun 11, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Service | 602.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hemostatic Agent | 443.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hemostatic Agent Growth | 28.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Catheter | 263.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Catheter Growth | 946.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Non-implantable Vascular Access Devices (Grade 2) | 12.79M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
South Korea | 1.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 468.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 104.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 5.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hong Kong | 22.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hong Kong Growth | 58.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Greece | 5.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Greece Growth | -41.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 1.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | -50.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|